Correlation Between InMode and CONMED
Can any of the company-specific risk be diversified away by investing in both InMode and CONMED at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining InMode and CONMED into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between InMode and CONMED, you can compare the effects of market volatilities on InMode and CONMED and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in InMode with a short position of CONMED. Check out your portfolio center. Please also check ongoing floating volatility patterns of InMode and CONMED.
Diversification Opportunities for InMode and CONMED
Pay attention - limited upside
The 3 months correlation between InMode and CONMED is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding InMode and CONMED in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CONMED and InMode is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on InMode are associated (or correlated) with CONMED. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CONMED has no effect on the direction of InMode i.e., InMode and CONMED go up and down completely randomly.
Pair Corralation between InMode and CONMED
Given the investment horizon of 90 days InMode is expected to generate 0.85 times more return on investment than CONMED. However, InMode is 1.17 times less risky than CONMED. It trades about 0.06 of its potential returns per unit of risk. CONMED is currently generating about -0.1 per unit of risk. If you would invest 1,663 in InMode on December 28, 2024 and sell it today you would earn a total of 107.00 from holding InMode or generate 6.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
InMode vs. CONMED
Performance |
Timeline |
InMode |
CONMED |
InMode and CONMED Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with InMode and CONMED
The main advantage of trading using opposite InMode and CONMED positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if InMode position performs unexpectedly, CONMED can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CONMED will offset losses from the drop in CONMED's long position.InMode vs. TransMedics Group | InMode vs. Inspire Medical Systems | InMode vs. Insulet | InMode vs. DexCom Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |